open trial patients multiple sclerosis experience treatment Orthoclone patients multiple sclerosis MS progressive phase disease acute severe attack lasting month recovery acute severe T-cytopenia Fifteen patients treatment days Side effects common severe included hypotension nausea vomiting diarrhea fever myalgia patients transient major rise levels interferon gamma tumor necrosis factor first hours treatment new clinical MRI activity MS period treatment many patients disability scores conclusion follow-up patients points Expanded Disability Status Scale Kurtzke EDSS stabilization rate patients complications MS EDSS patients clinical improvement year follow-up attendant toxicity unlikely major role treatment MS 